The use of unlicensed and off-label medicines in the neonate

Impicciatore, 1999, Status of new medicines approved by the European Medicines Evaluation Agency regarding paediatric use, Br J Clin Pharmacol, 48, 15, 10.1046/j.1365-2125.1999.00981.x Ceci, 2002, Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products, Eur J Clin Pharmacol, 58, 495, 10.1007/s00228-002-0511-0 t'Jong, 2001, Information for paediatric use of medicines in a product information compendium, Paediatr Perinatal Drug Ther, 4, 148 Mudur, 2004, Indian Medical Association wants off-label prescribing, Br Med J, 328, 974, 10.1136/bmj.328.7446.974-c Sharma, 2004, Indian experts protest against off-label drug use, Lancet, 363, 1372, 10.1016/S0140-6736(04)16088-1 Committee on Drugs, 1978, Unapproved uses of approved drugs: the physician, the package insert, and the FDA, Pediatrics, 62, 262, 10.1542/peds.62.2.262 Committee on Drugs, 1996, Unapproved uses of approved drugs: the physician, the package insert, and the Food and Drug Administration: subject review, Pediatrics, 98, 143, 10.1542/peds.98.1.143 Bendall, 1999, The prescription and supply of drugs in children from a legal viewpoint, Paediatr Perinatal Drug Ther, 3, 49 Royal College of Paediatrics and Child Health and the Neonatal and Paediatric Pharmacists Group, 2003 Joint RCPCH/NPPG Standing Committee on Medicines, 2000 Hull, 1999, Birth of a formulary, Arch Dis Child, 81, 197, 10.1136/adc.81.3.197 Choonara, 1995, Editorial: medicines for children, J Pharm Med, 5, 95 Brion, 2003, Extemporaneous (magistral) preparation of oral medicines for children in European hospitals, Acta Paediatr, 92, 486, 10.1111/j.1651-2227.2003.tb00583.x Turner, 2000, Unlicensed and off-label drug use in Australia, Paediatr Perinatal Drug Ther, 4, 24, 10.1185/1463009001527714 Conroy, 1998, Optimal dosing schedules with gentamicin are needed for premature neonates, Br Med J, 317, 204 Conroy, 2003, The use of gentamicin in the neonate, JPPT, 8, 60 Conroy, 1999, Unlicensed and off label drug use in neonates, Arch Dis Child Fetal Neonatal Ed, 80, F142, 10.1136/fn.80.2.F142 Turner, 1999, Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study, Acta Paediatr, 88, 965, 10.1111/j.1651-2227.1999.tb00191.x Avenel, 2000, Incidence of prescriptions without product licence in a neonatal intensive care unit [French], Arch Pediatr, 7, 143, 10.1016/S0929-693X(00)88083-5 Barr, 2002, Unlicensed and off-label medication use in a neonatal intensive care unit: a prospective study, Am J Perinatol, 19, 67, 10.1055/s-2002-23557 't Jong, 2000, Unapproved and off-label use of drugs in a children's hospital, N Engl J Med, 343, 1125, 10.1056/NEJM200010123431515 't Jong, 2001, A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital, Pediatrics, 108, 1089, 10.1542/peds.108.5.1089 O'Donnell, 2002, Unlicensed and off-label drug use in an Australian neonatal intensive care unit, Pediatrics, 110, e52, 10.1542/peds.110.5.e52 Chalumeau, 2000, Off label and unlicensed drug use among French office based paediatricians, Arch Dis Child, 83, 502, 10.1136/adc.83.6.502 't Jong, 2003, Determinants for drug prescribing to children below the minimum licensed age, Eur J Clin Pharmacol, 58, 701, 10.1007/s00228-002-0554-2 Rylance, 1979, The therapeutic underprivileged, Dev Med Child Neurol, 21, 399, 10.1111/j.1469-8749.1979.tb01638.x Shirkey, 1968, Therapeutic Orphans, J Pediatrics, 72, 119, 10.1016/S0022-3476(68)80414-7 Chappell, 2004, Potential tenfold drug overdoses on a Neonatal Unit, Arch Dis Child, 6, 20 Davies C. Junior doctor is cleared in baby overdose death 1999. http://www.portal.telegraph.co.uk/htmlContent.jhtml?html=/archive/1999/04/21/ndoc21.html (accessed 19/10/2003). Gill, 1995, Adverse drug reactions in a paediatric intensive care unit, Acta Paediatr, 84, 438, 10.1111/j.1651-2227.1995.tb13667.x Clarkson, 2001, A novel scheme for the reporting of adverse drug reactions, Arch Dis Child, 84, 337, 10.1136/adc.84.4.337 Clarkson A, Conroy S, Burroughs K, Choonara I. Surveillance for adverse drug reactions in children: a Paediatric Regional Monitoring Centre. Paediatr Perinatal Drug Ther; 2004 (in press). Impicciatore, 2002, Adverse drug reactions to off-label drugs on a paediatric ward: an Italian prospective pilot study, Paediatr Perinatal Drug Ther, 5, 19, 10.1185/146300902322125118 Horen, 2002, Adverse drug reactions and off-label drug use in paediatric outpatients, Br J Clin Pharmacol, 54, 665, 10.1046/j.1365-2125.2002.t01-3-01689.x Department of Health and Human Services, US Food and Drug Administration. The Pediatric Exclusivity Provision; January 2001: Status Report to Congress. Food and Drug Administration. Available online: http://www.fda.gov/opacom/laws/pharmkids/contents.html (accessed 22.4.04). Kearns, 1999, The pediatric pharmacology research unit network: proof of concept, Paediatr Perinatal Drug Ther, 3, 9 Licensing Medicines for Children. Joint report of the British Paediatric Association and the Association of the British Pharmaceutical Industry. London 1996. Health Committee. The specific health needs of children and young people. House of Commons Health Committee Second report, vol. 1 Session 1996–7 London, 1997. Conroy, 2002, A positive step forwards for paediatric medicine, Hospital Pharmacy Europe, 4, 78